EM 405: a new substance with an uncommon profile of anti-inflammatory activity.
Selve
N
N
Department of Pharmacology, Center of Research, Grünenthal GmbH, Aachen.
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000996:Antitussive Agents / Q000627:therapeutic use*; D002351:Carrageenan; D003231:Conjunctivitis / Q000188:drug therapy / Q000276:immunology; D003510:Cyclohexanes / Q000627:therapeutic use*; D053138:Cyclohexenes; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy / Q000209:etiology; D007249:Inflammation / Q000188:drug therapy*; D051379:Mice; D010047:Ovalbumin / Q000276:immunology; D051381:Rats; D014466:Ultraviolet Rays
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000996:Antitussive Agents; D003510:Cyclohexanes; D053138:Cyclohexenes; C069436:EM 405; D002351:Carrageenan; D010047:Ovalbumin